STML - Stemline Therapeutics Inc. (STML) CEO Ivan Bergstein on Q3 2019 Results - Earnings Call Transcript
Stemline Therapeutics, Inc. (STML)
Q3 2019 Earnings Conference Call
November 8, 2019, 08:00 AM ET
Company Participants
Kenneth Hoberman - COO
Ivan Bergstein - CEO
Robert Francomano - SVP, Global Head, Commercial
David Gionco - CAO
Conference Call Participants
Jessica Fye - JPMorgan
Boris Peaker - Cowen
Matt Kaplan - Ladenburg Thalmann
Charles Frantzreb - Piper Jaffray
Edward Marks - H.C. Wainwright
Presentation
Operator
Good day and welcome to the Stemline Earnings Conference Call. Today's conference is being recorded.
At this time, I would like to turn the conference over to Mr. Ken Hoberman. Please